
The Philippine government has signed an agreement to secure the supply of 30 million doses of the COVID-19 vaccine Covovax from India which will be available starting third quarter of this year.
Vaccine Czar Secretary Carlito Galvez Jr., Serum Institute of India and Faberco Life Sciences, Inc., signed a term sheet on January 9, 2021.
Serum Institute of India , the world’s largest vaccine manufacturer, partnered with Novavax, a US-based biotechnology company for the development and commercialization of the Covovax vaccine.
Covovax is in third-stage trials and expected to be approved for use by international regulators.
“The vaccine will be used to vaccinate 15 million vulnerable and poor Filipinos. The vaccine is stable at 2°C to 8°C, the standard temperature that is within the existing cold chain system in the Philippines, thus allowing its distribution to the remotest barangays,” said Faberco Life Sciences Medical Director Dr. Luningning Villa.
The price of the vaccine is expected to be finalized soon between the government and Serum Institute of India, which is noted for providing effective, safe and affordable vaccines across the globe through the decades.
The post PH gov’t inks deal for 30M doses of COVOVAX appeared first on UNTV News.